Association between seizures and diabetes mellitus: A comprehensive review of literature

Current Diabetes Reviews

Volumn 9, Issue 4, 2013, Pages 350-354

  Yun, Chen ^a   Xuefeng, Wang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Association; Diabetes mellitus; Pathogenesis; Seizures; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; PHENYTOIN; TOPIRAMATE; ZONISAMIDE;

ARTICLE; AUTOIMMUNE DISEASE; BRAIN DAMAGE; CEREBROVASCULAR DISEASE; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; EPILEPTIC STATE; FOCAL EPILEPSY; GENE MUTATION; GENERALIZED EPILEPSY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IMMUNOPATHOLOGY; MICROANGIOPATHY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SEIZURE;

EID: 84892952179     PISSN: 15733998     EISSN: 18756417     Source Type: Journal    
DOI: 10.2174/15733998113099990060     Document Type: Article

References (44)

1. Schober E, Otto KP, Dost A, Jorch N, Holl R. Association of epilepsy and type 1 DM in children and adolescents: Is there an increased risk for diabetic ketoacidosis? J Pediatr 2012; 160: 662-666 e661.
2. Engel R, Halberg F, Ziegler M, Mc QI. Observations on two children with DM and epilepsy. J Lancet 1952; 72: 242-248.
3. Cochin JP, Hannequin D, Delangre T, Guegan-Massardier E, Augustin P. continuous partial epilepsy disclosing DM. Rev Neurol (Paris) 1994; 150: 239-241.
4. Olson JA, Olson DM, Sandborg C, Alexander S, Buckingham B. Type 1 DM and epilepsia partialis continua in a 6-year-old boy with elevated anti-gad65 antibodies. Pediatrics 2002; 109: E50.
5. Peltola J, Kulmala P, Isojarvi J, et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000; 55: 46-50.
6. Wagner VM, Rosenbauer J, Grabert M, Holl RW. Severe hypoglycemia, metabolic control, and diabetes management in young children with type 1 diabetes using insulin analogs-a follow-up report of a large multicenter database. Eur J Pediatr 2008; 167: 241-242.
7. de Oliveira Iglesias SB, Pons Leite H, de Carvalho WB. Hypophosphatemia-induced seizure in a child with diabetic ketoacidosis. Pediatr Emerg Care 2009; 25: 859-861.
8. Ko CH, Kong CK. Topiramate-induced metabolic acidosis: Report of two cases. Dev Med Child Neurol 2001; 43: 701-704.
9. McCorry D, Nicolson A, Smith D, et al. An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 2006; 59: 204-206.
10. Ramakrishnan R, Appleton R. Study of prevalence of epilepsy in children with type 1 DM. Seizure 2012; 21: 292-294.
11. Whiting S, Camfield P, Arab D, Salisbury S. Insulin-dependent DM presenting in children as frequent, medically unresponsive, partial seizures. J Child Neurol 1997; 12: 178-180.
12. Daneman D, Frank M, Perlman K, Tamm J, Ehrlich R. Severe hypoglycemia in children with insulin-dependent DM: Frequency and predisposing factors. J Pediatr 1989; 115: 681-685.
13. Bulsara MK, Holman CD, Davis EA, Jones TW. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care 2004; 27: 2293-2298.
14. Tsalikian E, Becker DJ, Crumrine PK, Daneman D, Drash AL. Electroencephalographic changes in diabetic ketosis in children with newly and previously diagnosed insulin-dependent DM. J Pediatr 1981; 99: 355-359.
15. Haumont D, Dorchy H, Pelc S. Eeg abnormalities in diabetic children: Influence of hypoglycemia and vascular complications. Clin Pediatr (Phila) 1979; 18: 750-753.
16. Tupola S, Saar P, Rajantie J. Abnormal electroencephalogram at diagnosis of insulin-dependent DM may predict severe symptoms of hypoglycemia in children. J Pediatr 1998; 133: 792-794.
17. Baekkeskov S, Aanstoot HJ, Christgau S, et al. Identification of the 64k autoantigen in insulin-dependent diabetes as the gabasynthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-156.
18. Vianello M, Tavolato B, Giometto B. Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci 2002; 23: 145-151.
19. Errichiello L, Perruolo G, Pascarella A, et al. Autoantibodies to glutamic acid decarboxylase (gad) in focal and generalized epilepsy: A study on 233 patients. J Neuroimmunol 2009; 211: 120-123.
20. Striano P, Perruolo G, Errichiello L, et al. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes. Ann Neurol 2008; 63: 127-128.
21. Vulliemoz S, Seeck M. An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol 2006; 59: 728.
22. Mukherjee V, Mukherjee A, Halder A. Type i DM in a child presenting with epilepsy partialis continua. J Indian Med Assoc 2007; 105: 340, 342.
23. Yoshimoto T, Doi M, Fukai N, et al. Type 1 DM and drug-resistant epilepsy: Presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Intern Med 2005; 44: 1174-1177.
24. Caietta E, Halbert C, Lepine A, et al. Association of type 1 DM and epilepsy in children. A cohort of 10 cases. Arch Pediatr 2012; 19: 9-16.
25. Kwan P, Sills GJ, Kelly K, Butler E, Brodie MJ. Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: A pilot study. Epilepsy Res 2000; 42: 191-195.
26. Kashihara K, Shohmori T, Otsuki S. Noninsulin-dependent DMrelated encephalopathy presenting with amnesia, personality change, and autonomic seizure. Intern Med 1997; 36: 633-636.
27. Schomer DL. Focal status epilepticus and epilepsia partialis continua in adults and children. Epilepsia 1993; 34 Suppl 1: S29-36.
28. Lapenta L, Di Bonaventura C, Fattouch J, et al. Focal epileptic seizure induced by transient hypoglycaemia in insulin-treated diabetes. Epileptic Disord 2010; 12: 84-87.
29. Hauser E, Strohmayer C, Seidl R, et al. Quantitative eeg in young diabetics. J Child Neurol 1995; 10: 330-334.
30. Lahat E, Barr J, Bistritzer T. Focal epileptic episodes associated with hypoglycemia in children with diabetes. Clin Neurol Neurosurg 1995; 97: 314-316.
31. Zwaveling-Soonawala N, Hagebeuk EE, Slingerland AS, et al. Successful transfer to sulfonylurea therapy in an infant with developmental delay, epilepsy and neonatal diabetes (dend) syndrome and a novel abcc8 gene mutation. Diabetologia 2011; 54: 469-471.
32. Slingerland AS, Nuboer R, Hadders-Algra M, Hattersley AT, Bruining GJ. Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the v59m mutation in the kcnj11 gene. Diabetologia 2006; 49: 2559-2563.
33. Poulton CJ, Schot R, Kia SK, et al. Microcephaly with simplified gyration, epilepsy, and infantile diabetes linked to inappropriate apoptosis of neural progenitors. Am J Hum Genet 2011; 89: 265-276.
34. Cossette P, Liu L, Brisebois K, et al. Mutation of gabra1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2002; 31: 184-189.
35. Tedrus GM, Albertin MC, Odashima NS, Fonseca LC. partial motor seizures induced by movement in diabetic patients. Arq Neuropsiquiatr 1991; 49: 442-446.
36. Guerreiro CA, Falcao AE, Silveira DC. focal seizures in nonketotic hyperglycemia. Arq Neuropsiquiatr 1991; 49: 447-449.
37. Hennis A, Corbin D, Fraser H. Focal seizures and non-ketotic hyperglycaemia. J Neurol Neurosurg Psychiatry 1992; 55: 195-197.
38. Tedrus GM, Fonseca LC, De Tella LM, Viana MA. de novo absence status: Case report. Arq Neuropsiquiatr 1997; 55: 642-645.
39. Mancardi MM, Striano P, Giannattasio A, et al. Type 1 diabetes and epilepsy: More than a casual association? Epilepsia 2010; 51: 320-321.
40. O'Connell MA, Harvey AS, Mackay MT, Cameron FJ. Does epilepsy occur more frequently in children with type 1 diabetes? J Paediatr Child Health 2008; 44: 586-589.
41. Batista MS, Silva DF, Ferraz HB, de Andrade LA. Complex partial seizures and aphasia as initial manifestations of non-ketotic hyperglycemia. Case report. Arq Neuropsiquiatr 1998; 56: 296-299.
42. Roze E, Oubary P, Chedru F. Status-like recurrent pilomotor seizures: Case report and review of the literature. J Neurol Neurosurg Psychiatry 2000; 68: 647-649.
43. Dressler A, Reithofer E, Trimmel-Schwahofer P, et al. Type 1 diabetes and epilepsy: Efficacy and safety of the ketogenic diet. Epilepsia 2010; 51: 1086-1089.
44. Lopes CD, de Albuquerque M, Lopes AC, Arida RM, Scorza FA. Sudden unexpected death in epilepsy: Trying to reset the clock on diabetes. Epilepsy Behav 2012; 24: 517-8.